regulatory approval

NICE Recommends AstraZeneca's Imfinzi for PD-L1-Positive NSCLC

Bristol Myers Squibb's Breyanzi Approved in Europe for Lymphoma Patients

Xcovery's Ensartinib Approved for First-Line ALK-Positive NSCLC in China

Burning Rock Secures Lung Cancer NGS Test Regulatory Approval in China

Pfizer's Lorviqua Approved in EU for First-Line Treatment of ALK-Positive Advanced Lung Cancer

FDA Approves Immunocore's T-Cell Receptor Therapy Kimmtrak for Uveal Melanoma Patients

CStone, Blueprint Medicines' Ayvakit Nets Hong Kong Approval for Biomarker-Defined GIST

European Commission Approves Roche's Gavreto for RET Fusion-Positive NSCLC

European Commission Approves Merck's Keytruda-Chemo Combination for Advanced TNBC Patients

FDA Approves Gilead's Tecartus for Acute Lymphoblastic Leukemia

Pillar Biosciences Receives FDA Approval for OncoReveal Dx Lung and Colon Cancer Assay

NICE Recommends Incyte's Pemazyre for FGFR2-Positive Bile Duct Cancer

Merck's Keytruda Plus Chemo Approved in Europe for Certain Gastroesophageal Cancers

BMS' Opdivo, Yervoy Combo Approved for dMMR, MSI-High Colorectal Cancer in Europe

Chinese Regulators Approve Lynparza for BRCA1/2-Mutated mCRPC

FDA Approves Blueprint Medicines' Ayvakit for Advanced Systemic Mastocytosis

Hansoh Pharma, EQRx Planning Regulatory Talks After Positive Phase III Aumolertinib Data in NSCLC

European Commission Approves GSK's Dostarlimab in Endometrial Cancer

FDA Approves GSK's Jemperli With Ventana CDx for dMMR Endometrial Cancer